This research develops small-molecule treatments for chikungunya virus using a lock-and-key approach targeting viral proteins. A key challenge—molecular orientation (enantiomers)—was addressed with a new synthesis method producing over 95% effective molecules. The optimized compound, BDGR-651, shows promise as a future antiviral treatment for this debilitating disease.

This project uses virtual reality to turn drug design into a spatial puzzle game. By fitting molecular “drug” shapes into protein grooves—much like Tetris—players can exploit human spatial intuition to explore new treatments. Using Nano Simbox software, VR proved over ten times more effective than other platforms for complex molecular tasks.